Former President Joe Biden announced this weekend that he has been diagnosed with an aggressive form of prostate cancer, the second leading cause of cancer death for men in the United States. About 1 ...
This is a retrospective study of patients with metastatic Pca, diagnosed at King Hussein Cancer Center, Jordan, between 2006 and 2018. Survival was estimated using the Kaplan-Meier method and compared ...
PET/CT offers excellent accuracy in the staging of high-risk prostate cancer (PCa), yet outcomes-based evidence of the clinical benefit remains limited. We aimed to determine whether the rates of ...
We read with interest the systematic review by C Tang and colleagues1 and compliment the authors for their comprehensive primary analysis of six randomised clinical trials (RCTs) comparing ...
Prostate-cancer screening based on prostate-specific antigen (PSA) levels in the blood was introduced—and readily adopted—in the United States around the late 1980s. But this screening method, in ...
Our study found that PZ biopsies offer no additional benefit for TZ lesion tumors, and increasing the number of cores in the TZ region can compensate for the current limitations of TZ biopsies. These ...
Opportunistic prostate cancer screening can lead to overdiagnosis of indolent diseases and invasive procedures. A cohort study suggested that a low baseline PSA level in midlife was associated with a ...
A large analysis of two major clinical trials has found that the spread of prostate cancer can be detected on imaging scans ...
Routine PSA testing is not recommend by the USPSTF for men 70 and older, a group expected to derive little benefit. Similar to trends in the U.S., this U.K. study found that a high number of older men ...
Source: Getty Images Investigators report findings from an analysis of 20-year follow-up data from the ERSPC. Men who consistently avoid prostate cancer screening appointments face a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results